Vivo Biosciences Inc
Vivo Biosciences Inc., founded in 2004 and headquartered in Birmingham, AL, is an innovative biotech company focused on developing advanced bioassay platforms for preclinical research, drug discovery, and therapeutics. Utilizing its patented HuBiogel technology, the company offers high-value solutions that emulate normal and diseased tissues in vitro, aimed at enhancing drug efficacy, toxicity analysis, and therapy prediction.
Under the leadership of experienced professionals, including founder Dr. Singh and distinguished board members, Vivo Biosciences is committed to pioneering research in selective androgen receptor modulators (SARMs), peptides, and cannabinoids. Their work not only addresses pressing challenges in oncology and drug development but also positions the company as a leader in the biotechnology field with a global outreach to academic, commercial, and government institutions.
Generated from the website